Onasemnogene abeparvovec (Zolgensma)

Status:
Red
Decision Date:
July 2021
 

Comments

RED: NICE HST15 for treating spinal muscular atrophy. (Decision date - August 2021)

RED: NICE HST24 - for treating presymptomatic spinal muscular atrophy. (Partial Review of HST15). (Decision date - May 2023)

Red Drug Classifications

  • 8. NHS England commissioned – to be used in line with NHSE commissioning intentions

search again

Derby and Derbyshire ICB

Derby and Derbyshire ICB

Please click the button to navigate to our app

Redirect to app